NASDAQ Biotechnology Index ETF Overview

With 3 ETFs traded on the U.S. markets, NASDAQ Biotechnology Index ETFs have total assets under management of $10.23B. The average expense ratio is 0.79%. NASDAQ Biotechnology Index ETFs can be found in the following asset classes:

  • Equity

The largest NASDAQ Biotechnology Index ETF is the iShares Biotechnology ETF IBB with $10.01B in assets. In the last trailing year, the best-performing NASDAQ Biotechnology Index ETF was BIB at 36.22%. The most recent ETF launched in the NASDAQ Biotechnology Index space was the ProShares Ultra NASDAQ Biotechnology BIB on 04/07/10.

Daily ETF Watch

ETF Odds & Ends: Vanguard Share Splits

Plus, several funds undergo name and index changes. 

Features and News

Sleeper Hit ETF Of 2020

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Daily ETF Watch

Junior Biotech ETF Debuts

New fund invests in small cap biotechnology stocks. 

ETF.com Analysis

Biotech ETFs: Appraising The Pipelines

Parsing the performance and holdings of different biotech funds.

ETF Report

Sectors In Review: May 2020

None of the sector ETFs managed to eke out a positive return during the month.

ETF Report

Sectors In Review: April 2020

February was awful for sectors, with just one fund recording positive returns.

Features and News

The Love & Hate Of Biotech ETFs

The volatile segment struggled to catch a break, then rallied, and now sits in the limelight of a virus outbreak.

ETF Report

Sectors In Review: January 2020

Sector ETFs had a great month, with most seeing positive returns.

ETF Report

 Sectors In Review: December 2019

A few sector ETFs faltered during the month